In our “Sequencing Buyers guide” written by David Smith, many commercial MPS platforms were reviewed with what they can be used for.
I’m Luigi Grassi and I’m an Informatics Scientist at AstraZeneca. I’m responsible for designing and performing bioinformatical analyses of the […]
The study, published in Nature yesterday, may change how cancer is diagnosed, and shape our understanding of how cancer interacts with microbes.
As headlines trumpet the continued spread of COVID-19, the wall-to-wall coverage has generated a secondary outbreak of breathless hype, misinformation and anxiety.
Arti Patel is an Information Officer at Unique, where she acts as the first point of contact on the helpline […]
FLG: Can you introduce yourself and your work? I’m Guillermo del Angel and I’m the Senior Director for Data Science […]
Aging affects everyone, right down to our genetic core, but there’s plenty of evidence showing that each individual experiences the effects of age differently. As it turns out, some people are predisposed to a less disruptive (a kinder, gentler) aging process. New research hopes to uncover why that is.
The State University of New York (SUNY) is running the program with $20 million funding from the Empire State Development’s […]
With the falling cost of genome sequencing, it comes as no surprise that there is a growing interest in expanding the availability and accessibility of genomics via consumer testing. Now, Nebula Genomics has entered the market by launching a comprehensive at-home test that analyses the whole genome for just $299.
Helen C. O’Neill has explored how the global reaction to the birth of genome-edited twins in 2018 echoed the condemnation […]
